Clopidogrel Preventive Effect Based on CYP2C19 Genotype in Ischemic Stroke
A Multicenter Prospective observationaL Study to evAluate the effecT of Clopidogrel on the prEvention of Major vascuLar Events According to the gEnotype of Cytochrome P450 2C19 in Ischemic Stroke paTients; PLATELET Study
Sponsor: Gangnam Severance Hospital
A observational or N/A phase clinical study on Acute Ischemic Stroke, this trial is completed. The trial is conducted by Gangnam Severance Hospital and has accumulated 13 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Oct 2023 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Nov 2022 — Oct 2023 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
▶ Show 8 earlier versions
-
Sep 2022 — Nov 2022 [monthly]
Recruiting
-
Dec 2021 — Sep 2022 [monthly]
Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Aug 2020 — Nov 2020 [monthly]
Recruiting
-
Dec 2019 — Aug 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Sep 2019 — Dec 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Gangnam Severance Hospital
- SAMJIN PHARM
For direct contact, visit the study record on ClinicalTrials.gov .